1. Herpes zoster viral infection after AZD1222 and BNT162b2 coronavirus disease 2019 mRNA vaccines: a case series. (10th October 2021) Authors: Koumaki, D.; Krueger‐Krasagakis, S.‐E.; Papadakis, M.; Katoulis, A.; Koumaki, V.; Evangelou, G.; Stefanidou, M.; Mylonakis, D.; Zografaki, K.; Krasagakis, K. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 2(2022) Page Start: e85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Psoriasis flare‐up after AZD1222 and BNT162b2 COVID‐19 mRNA vaccines: report of twelve cases from a single centre. (4th February 2022) Authors: Koumaki, D.; Krueger‐Krasagakis, S.‐E.; Papadakis, M.; Katoulis, A.C.; Gkiaouraki, I.; Zografaki, K.; Mylonakis, D.; Krasagakis, K. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 6(2022) Page Start: e411 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗